HALO.US — market event timeline

nashnova tracks 2 market events mentioning HALO.US as of 2026-09-28, each with a dated one-line analysis of how the event relates to the asset.

  1. Eli Lilly CEO: Seeking Larger-Scale M&A, Eyeing Infectious Disease and Women's Health

    Mid-cap biopharma company involved in infectious diseases, falling within Eli Lilly's potential acquisition target scope; M&A expectations could boost its valuation.

  2. Merck's Keytruda Subcutaneous Injection Approved for Launch in China

    Keytruda's subcutaneous formulation utilizes Halozyme's ENHANZE hyaluronidase technology platform; the approval will trigger milestone payments and royalties.

For research and information only — not investment advice.